Long-Term Management of Migraine With OnabotulinumtoxinA (Botox) vs Calcitonin Gene-Related Peptide Antibodies (Anti-CGRP)

In this literature review, we will evaluate the effectiveness of OnabotulinumtoxinA (Botox) and anti-calcitonin gene-related peptide (anti-CGRP) in the treatment of migraine headaches. Both therapies are frequently prescribed for managing and preventing migraines and have received Food and Drug Admi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pallapothu, Manoj R, Quintana Mariñez, Maria G, Chakkera, Mohana, Ravi, Niriksha, Ramaraju, Rajita, Vats, Aastha, Nair, Athira R, Bandhu, Atithi K, Koirala, Divya, Mohammed, Lubna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630153/
https://www.ncbi.nlm.nih.gov/pubmed/38021691
http://dx.doi.org/10.7759/cureus.46696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630153/
https://www.ncbi.nlm.nih.gov/pubmed/38021691
http://dx.doi.org/10.7759/cureus.46696

Ejemplares similares